VKTX
Viking Therapeutics·NASDAQ
--
--(--)
--
--(--)
VKTX fundamentals
Viking Therapeutics (VKTX) expects to report earnings on Feb 11, 2026, with estimated revenue of 0 (YoY 0.00%), and EPS at -0.8972 (YoY -180.38%).
Revenue estimate / YoY
0
0.00%
EPS estimate / YoY
-0.8972
-180.38%
Report date
Feb 11, 2026
Earnings Call
4:30 PM on Feb 11, 2026
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Viking Therapeutics (VKTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Viking Therapeutics (VKTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Viking Therapeutics (VKTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Viking Therapeutics (VKTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Viking Therapeutics (VKTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Viking Therapeutics (VKTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Viking Therapeutics do and what are its main business segments?What factors drove the changes in Viking Therapeutics's revenue and profit?What is Viking Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Viking Therapeutics’s earnings call?What is Viking Therapeutics's gross profit margin?What guidance did Viking Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Viking Therapeutics next quarter?What is the revenue and EPS growth rate for Viking Therapeutics year over year?
